- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-4-2-mer
- Ligands
- 4 x 6ZP: 2-(6'-oxo-1'-phenyl[1',6'-dihydro[2,3'-bipyridine]]-5'-yl)benzonitrile(Non-covalent)
- 4 x ZK1: {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid(Non-covalent)
ZK1.2: 13 residues within 4Å:- Chain A: E.393, Y.396, Y.441, P.469, L.470, T.471, R.476, G.644, S.645, T.677, E.696, M.699, Y.723
11 PLIP interactions:11 interactions with chain A- Hydrogen bonds: A:P.469, A:T.471, A:R.476, A:R.476, A:S.645, A:S.645, A:S.645, A:T.677, A:E.696
- pi-Stacking: A:Y.441, A:Y.441
ZK1.14: 14 residues within 4Å:- Chain B: E.393, Y.396, Y.441, P.469, L.470, T.471, R.476, G.644, S.645, T.677, E.696, T.698, M.699, Y.723
10 PLIP interactions:10 interactions with chain B- Hydrogen bonds: B:P.469, B:T.471, B:R.476, B:R.476, B:S.645, B:S.645, B:S.645, B:E.696
- pi-Stacking: B:Y.441, B:Y.441
ZK1.23: 13 residues within 4Å:- Chain C: E.393, Y.396, Y.441, P.469, L.470, T.471, R.476, G.644, S.645, T.677, E.696, M.699, Y.723
11 PLIP interactions:11 interactions with chain C- Hydrogen bonds: C:P.469, C:T.471, C:R.476, C:R.476, C:S.645, C:S.645, C:S.645, C:T.677, C:E.696
- pi-Stacking: C:Y.441, C:Y.441
ZK1.34: 14 residues within 4Å:- Chain D: E.393, Y.396, Y.441, P.469, L.470, T.471, R.476, G.644, S.645, T.677, E.696, T.698, M.699, Y.723
10 PLIP interactions:10 interactions with chain D- Hydrogen bonds: D:P.469, D:T.471, D:R.476, D:R.476, D:S.645, D:S.645, D:S.645, D:E.696
- pi-Stacking: D:Y.441, D:Y.441
- 28 x PCW: 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)(Non-functional Binders)
PCW.3: 14 residues within 4Å:- Chain A: K.502, P.503, G.504, V.505, F.506, Y.788, I.789, G.792, G.793, L.796
- Chain D: V.595
- Ligands: PCW.6, CLR.7, PCW.32
Ligand excluded by PLIPPCW.4: 14 residues within 4Å:- Chain A: M.518, F.522, Y.524, L.572, Y.854, K.993, Y.994, G.995, W.996, A.999, I.1003
- Ligands: PCW.5, PCW.6, PCW.32
Ligand excluded by PLIPPCW.5: 17 residues within 4Å:- Chain A: I.525, V.529, R.536, N.560, E.561, G.563, F.565, N.566, F.835, L.1006, S.1010, V.1013, M.1014, Y.1017
- Ligands: PCW.4, CLR.8, PCW.32
Ligand excluded by PLIPPCW.6: 13 residues within 4Å:- Chain A: F.506, Y.514, E.515, W.517, I.520, Y.524, F.575, Y.992, Y.994
- Chain D: F.598
- Ligands: PCW.3, PCW.4, PCW.32
Ligand excluded by PLIPPCW.9: 18 residues within 4Å:- Chain A: P.539, R.585, L.587, R.590, G.594, V.595, F.598
- Chain B: Y.524, F.565, L.568, L.572, M.576, I.789
- Ligands: PCW.15, PCW.16, PCW.17, CLR.20, PCW.44
Ligand excluded by PLIPPCW.10: 3 residues within 4Å:- Chain A: V.952, I.955
- Ligands: PCW.18
Ligand excluded by PLIPPCW.15: 13 residues within 4Å:- Chain A: V.595
- Chain B: K.502, G.504, V.505, F.506, Y.788, I.789, G.792, L.796, L.799
- Ligands: PCW.9, PCW.17, CLR.19
Ligand excluded by PLIPPCW.16: 18 residues within 4Å:- Chain B: F.522, Y.524, I.525, V.529, F.532, R.536, N.560, G.563, I.564, F.565, L.568
- Chain F: P.70, S.73, I.74, L.77, L.80
- Ligands: PCW.9, PCW.44
Ligand excluded by PLIPPCW.17: 16 residues within 4Å:- Chain A: F.598
- Chain B: F.506, Y.514, E.515, W.517, M.518, I.520, V.521, Y.524, L.572, F.575, M.576, I.789
- Ligands: PCW.9, PCW.15, PCW.44
Ligand excluded by PLIPPCW.18: 10 residues within 4Å:- Chain A: L.533, F.537, I.955, L.959
- Chain B: M.798, L.799, A.801, L.802, F.805
- Ligands: PCW.10
Ligand excluded by PLIPPCW.21: 20 residues within 4Å:- Chain B: Y.540, R.585, S.586, L.587, R.590, I.591, G.594, V.595, F.598
- Chain C: Y.524, F.565, L.568, W.569, L.572, I.789
- Ligands: PCW.24, PCW.25, PCW.26, PCW.27, CLR.29
Ligand excluded by PLIPPCW.24: 12 residues within 4Å:- Chain B: V.595
- Chain C: K.502, P.503, G.504, V.505, F.506, G.792, G.793, L.796
- Ligands: PCW.21, PCW.27, CLR.28
Ligand excluded by PLIPPCW.25: 15 residues within 4Å:- Chain C: M.518, F.522, Y.524, L.572, Y.854, K.993, Y.994, G.995, W.996, A.999, A.1002, I.1003
- Ligands: PCW.21, PCW.26, PCW.27
Ligand excluded by PLIPPCW.26: 19 residues within 4Å:- Chain C: I.525, V.529, R.536, N.560, E.561, G.563, I.564, F.565, N.566, F.835, L.1006, E.1009, S.1010, V.1013, M.1014, Y.1017
- Ligands: PCW.21, PCW.25, CLR.29
Ligand excluded by PLIPPCW.27: 13 residues within 4Å:- Chain B: F.598
- Chain C: F.506, Y.514, E.515, W.517, I.520, Y.524, F.575, Y.992, Y.994
- Ligands: PCW.21, PCW.24, PCW.25
Ligand excluded by PLIPPCW.30: 17 residues within 4Å:- Chain C: P.539, R.585, L.587, R.590, G.594, V.595, F.598
- Chain D: Y.524, F.565, L.568, W.569, L.572, I.789
- Ligands: PCW.35, PCW.36, PCW.37, CLR.40
Ligand excluded by PLIPPCW.31: 3 residues within 4Å:- Chain C: V.952, I.955
- Ligands: PCW.38
Ligand excluded by PLIPPCW.32: 21 residues within 4Å:- Chain A: Y.524, F.565, L.568, W.569, L.572, M.576, I.789
- Chain D: Y.540, R.585, S.586, L.587, R.590, I.591, G.594, V.595, F.598
- Ligands: PCW.3, PCW.4, PCW.5, PCW.6, CLR.8
Ligand excluded by PLIPPCW.35: 12 residues within 4Å:- Chain C: V.595
- Chain D: K.502, G.504, V.505, F.506, Y.788, I.789, G.792, L.799
- Ligands: PCW.30, PCW.37, CLR.39
Ligand excluded by PLIPPCW.36: 17 residues within 4Å:- Chain D: F.522, I.525, V.529, F.532, R.536, N.560, G.563, I.564, F.565, L.568
- Chain E: V.69, P.70, S.73, I.74, L.80
- Ligands: PCW.30, PCW.43
Ligand excluded by PLIPPCW.37: 16 residues within 4Å:- Chain C: F.598
- Chain D: F.506, Y.514, E.515, W.517, M.518, I.520, V.521, Y.524, L.572, F.575, M.576, I.789
- Ligands: PCW.30, PCW.35, PCW.43
Ligand excluded by PLIPPCW.38: 10 residues within 4Å:- Chain C: L.533, F.537, I.955, L.959
- Chain D: M.798, L.799, A.801, L.802, F.805
- Ligands: PCW.31
Ligand excluded by PLIPPCW.41: 8 residues within 4Å:- Chain A: G.795, M.798, L.799, A.801, L.802
- Chain D: L.533
- Chain E: A.18, F.22
Ligand excluded by PLIPPCW.42: 3 residues within 4Å:- Chain E: L.150, V.154
- Ligands: CLR.7
Ligand excluded by PLIPPCW.43: 9 residues within 4Å:- Chain D: M.518, Y.524
- Chain E: L.80, L.83, C.84, A.86, W.88
- Ligands: PCW.36, PCW.37
Ligand excluded by PLIPPCW.44: 9 residues within 4Å:- Chain B: M.518, Y.524
- Chain F: L.80, L.83, C.84, A.86
- Ligands: PCW.9, PCW.16, PCW.17
Ligand excluded by PLIPPCW.45: 9 residues within 4Å:- Chain B: L.533
- Chain C: G.795, M.798, L.799, A.801, L.802
- Chain F: A.18, S.19, F.22
Ligand excluded by PLIPPCW.46: 1 residues within 4Å:- Ligands: CLR.28
Ligand excluded by PLIP- 8 x CLR: CHOLESTEROL(Non-covalent)
CLR.7: 8 residues within 4Å:- Chain A: V.505, Y.788, V.791
- Chain E: L.14, M.153, L.157
- Ligands: PCW.3, PCW.42
4 PLIP interactions:2 interactions with chain E, 2 interactions with chain A- Hydrophobic interactions: E:L.14, E:L.157, A:Y.788, A:Y.788
CLR.8: 5 residues within 4Å:- Chain A: I.803, Y.807, K.808
- Ligands: PCW.5, PCW.32
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:Y.807, A:Y.807
CLR.19: 8 residues within 4Å:- Chain A: F.922, V.966, L.970
- Chain B: Y.788, V.791, G.792, G.795
- Ligands: PCW.15
7 PLIP interactions:4 interactions with chain A, 3 interactions with chain B- Hydrophobic interactions: A:F.922, A:V.966, A:V.966, A:L.970, B:Y.788, B:Y.788, B:Y.788
CLR.20: 7 residues within 4Å:- Chain A: L.587
- Chain B: V.800, I.803, E.804, Y.807, K.808
- Ligands: PCW.9
5 PLIP interactions:1 interactions with chain A, 4 interactions with chain B- Hydrophobic interactions: A:L.587, B:V.800, B:I.803, B:E.804, B:Y.807
CLR.28: 8 residues within 4Å:- Chain C: V.505, Y.788, V.791
- Chain F: L.14, M.153, L.157
- Ligands: PCW.24, PCW.46
5 PLIP interactions:3 interactions with chain C, 2 interactions with chain F- Hydrophobic interactions: C:Y.788, C:Y.788, C:V.791, F:L.14, F:L.157
CLR.29: 5 residues within 4Å:- Chain C: I.803, Y.807, K.808
- Ligands: PCW.21, PCW.26
2 PLIP interactions:2 interactions with chain C- Hydrophobic interactions: C:Y.807, C:Y.807
CLR.39: 8 residues within 4Å:- Chain C: V.966, L.970
- Chain D: V.505, Y.788, V.791, G.792, G.795
- Ligands: PCW.35
6 PLIP interactions:3 interactions with chain D, 3 interactions with chain C- Hydrophobic interactions: D:V.505, D:Y.788, D:Y.788, C:V.966, C:V.966, C:L.970
CLR.40: 6 residues within 4Å:- Chain C: L.587
- Chain D: I.803, E.804, Y.807, K.808
- Ligands: PCW.30
4 PLIP interactions:3 interactions with chain D, 1 interactions with chain C- Hydrophobic interactions: D:I.803, D:E.804, D:Y.807, C:L.587
- 1 x NA: SODIUM ION(Non-functional Binders)
- 1 x SPD: SPERMIDINE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Gangwar, S.P. et al., Modulation of GluA2-gamma 5 synaptic complex desensitization, polyamine block and antiepileptic perampanel inhibition by auxiliary subunit cornichon-2. Nat.Struct.Mol.Biol. (2023)
- Release Date
- 2023-09-06
- Peptides
- Glutamate receptor 2, Voltage-dependent calcium channel gamma-5 subunit chimera: ABCD
Protein cornichon homolog 2: EF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
F - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-4-2-mer
- Ligands
- 4 x 6ZP: 2-(6'-oxo-1'-phenyl[1',6'-dihydro[2,3'-bipyridine]]-5'-yl)benzonitrile(Non-covalent)
- 4 x ZK1: {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid(Non-covalent)
- 28 x PCW: 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)(Non-functional Binders)
- 8 x CLR: CHOLESTEROL(Non-covalent)
- 1 x NA: SODIUM ION(Non-functional Binders)
- 1 x SPD: SPERMIDINE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Gangwar, S.P. et al., Modulation of GluA2-gamma 5 synaptic complex desensitization, polyamine block and antiepileptic perampanel inhibition by auxiliary subunit cornichon-2. Nat.Struct.Mol.Biol. (2023)
- Release Date
- 2023-09-06
- Peptides
- Glutamate receptor 2, Voltage-dependent calcium channel gamma-5 subunit chimera: ABCD
Protein cornichon homolog 2: EF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
F - Membrane
-
We predict this structure to be a membrane protein.